A Multicenter, Randomized, Double-blind, Parallel, Vehicle-controlled Study to Evaluate the Efficacy and Safety of P-3058 10% Nail Solution in the Treatment of Onychomycosis
Withdrawn prior to enrolment
Phase of Trial: Phase III
Latest Information Update: 12 Jan 2018
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Therapeutic Use
- Sponsors Polichem
- 12 Jan 2018 Status changed from not yet recruiting to withdrawn prior to enrolment.
- 19 Dec 2016 New trial record
- 07 Nov 2016 According to an Almirall S.A. media release, this trial will initiate in 1Q2017.